Clinical differentiation between pediatric pulmonary tuberculosis and Mycoplasma pneumoniae pneumonia (Review)

Differentiating between pediatric pulmonary tuberculosis (TB) and Mycoplasma pneumoniae pneumonia (MPP) is essential due to their overlapping clinical manifestations yet distinct therapeutic approaches. TB is characterized by a chronic progression, accompanied by constitutional symptoms and specific radiological features such as lymphadenopathy and 'tree-in-bud' patterns. By contrast, MPP typically presents with an acute onset, marked by a severe paroxysmal dry cough, and is associated with patchy consolidation and ground-glass opacities on imaging studies. Accurate diagnosis relies on molecular assays, such as Xpert MTB/RIF and PCR, alongside serological testing. The treatment regimen for TB involves prolonged administration of multiple drugs, whereas MPP is generally managed with macrolide antibiotics, although rising resistance is a concern. Therefore, the integration of clinical, radiological, and laboratory data is imperative for precise diagnosis and effective management.